`Amendment dated: April 19, 2019
`Reply to Office Action dated February 1, 2019
`
`REMARKS/ARGUMENTS:
`
`Applicant thanks the Examiner for the careful consideration given the present
`
`application, and respectfully requests favorable reconsideration of the application in view
`
`of the comments set forth below.
`
`Claim 1 has been amended.
`
`Support for the amendments is provided,
`
`for
`
`example, in paragraphs [0050] and [0057] of the originally filed Specification. No new
`
`matter has been added.
`
`Specification
`
`The Specification was objected to because of informalities. Applicant has
`
`amended the Specification to obviate the objection. Accordingly, Applicant respectfully
`
`requests that the objection to the Specification be withdrawn.
`
`Claim Rejections 35 USC § 112 / Claim Interpretation
`
`Claims 1-4 were rejected under 35 U.S.C. §112(a), or pre—AIA 35 U.S.C. §112,
`
`first paragraph, as failing to comply with the enablement requirement. At least for the
`
`following reasons, the rejection is respectfully traversed.
`
`The Office action alleges that
`
`the specification fails to provide description
`
`regarding the structure of the “voltage application section”, “measurement section”,
`77
`“determination section”, and “control section. However, as described, for example in
`
`paragraph [0037], a voltage can be applied to the input terminal under the control of the
`
`control section,
`
`in paragraph [0052], the control section can apply a voltage between
`
`electrodes of the biosensor, in paragraphs [0062], [0069], and [0086], information can be
`
`displayed on the display through the control section, and in paragraphs [0074] and
`
`[0089], the control section can measure blood-sugar level on the basis of an electric
`
`current value.
`
`In view of these descriptions, one of ordinary skill in the art would have
`
`understood the “voltage application section”, “measurement section”, “determination
`
`Page 5 of 10
`
`